NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,640,000 | -31.8% | 243,887 | -23.6% | 0.01% | -28.6% |
| Q4 2021 | $25,877,000 | -20.5% | 319,193 | +14.1% | 0.01% | -30.0% |
| Q3 2021 | $32,546,000 | -10.2% | 279,651 | +27.9% | 0.01% | -9.1% |
| Q2 2021 | $36,236,000 | +90.8% | 218,566 | +60.5% | 0.01% | +83.3% |
| Q1 2021 | $18,992,000 | -21.3% | 136,144 | -2.3% | 0.01% | -25.0% |
| Q4 2020 | $24,129,000 | +26.6% | 139,392 | +1.9% | 0.01% | +14.3% |
| Q3 2020 | $19,059,000 | +13.8% | 136,820 | -2.4% | 0.01% | 0.0% |
| Q2 2020 | $16,747,000 | +12.9% | 140,180 | -5.6% | 0.01% | 0.0% |
| Q1 2020 | $14,839,000 | -16.3% | 148,418 | -1.6% | 0.01% | 0.0% |
| Q4 2019 | $17,734,000 | +14.5% | 150,876 | -16.3% | 0.01% | +16.7% |
| Q3 2019 | $15,494,000 | +11.5% | 180,229 | -15.9% | 0.01% | 0.0% |
| Q2 2019 | $13,890,000 | +23.7% | 214,254 | +19.3% | 0.01% | +20.0% |
| Q1 2019 | $11,229,000 | -29.0% | 179,629 | -35.2% | 0.01% | -28.6% |
| Q3 2018 | $15,806,000 | -32.9% | 277,306 | -6.1% | 0.01% | -30.0% |
| Q2 2018 | $23,573,000 | -9.1% | 295,214 | -1.3% | 0.01% | -9.1% |
| Q1 2018 | $25,921,000 | +26.7% | 299,078 | +0.9% | 0.01% | +22.2% |
| Q4 2017 | $20,464,000 | +29.3% | 296,407 | +70.2% | 0.01% | +28.6% |
| Q3 2017 | $15,823,000 | +22.8% | 174,108 | +0.6% | 0.01% | +16.7% |
| Q2 2017 | $12,880,000 | +29.1% | 173,046 | +62.5% | 0.01% | +20.0% |
| Q1 2017 | $9,980,000 | +45.5% | 106,510 | +12.8% | 0.01% | +66.7% |
| Q4 2016 | $6,859,000 | -10.7% | 94,403 | -43.0% | 0.00% | -25.0% |
| Q3 2015 | $7,685,000 | -99.9% | 165,672 | -0.1% | 0.00% | -20.0% |
| Q2 2015 | $8,910,407,000 | -11.1% | 165,775 | -20.8% | 0.01% | 0.0% |
| Q1 2015 | $10,027,004,000 | -12.5% | 209,201 | -29.4% | 0.01% | -16.7% |
| Q4 2014 | $11,463,876,000 | – | 296,454 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |